• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泌尿道癌症中的外泌体:新兴的药物耐药性介质和有前途的生物标志物。

Exosomes in Genitourinary Cancers: Emerging Mediators of Drug Resistance and Promising Biomarkers.

机构信息

Department of Urology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.

出版信息

Int J Biol Sci. 2023 Jan 1;19(1):167-182. doi: 10.7150/ijbs.78321. eCollection 2023.

DOI:10.7150/ijbs.78321
PMID:36594094
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9760437/
Abstract

Drug resistance presents a major obstacle in the treatment of genitourinary cancers. Exosomes as the medium of intercellular communication serve important biological functions and play essential roles in pathological processes, including drug response. Through the transfer of bioactive cargoes, exosomes can modulate drug resistance via multiple mechanisms. This review attempts to elucidate the mechanisms of exosomal cargoes with reference to tumor drug resistance, their role in genitourinary cancers, and their potential clinical applications as candidate biomarkers in liquid biopsy.

摘要

耐药性是泌尿生殖系统癌症治疗的主要障碍。外泌体作为细胞间通讯的介质,具有重要的生物学功能,并在包括药物反应在内的病理过程中发挥重要作用。通过传递生物活性货物,外泌体可以通过多种机制调节耐药性。本综述试图阐明与肿瘤耐药性相关的外泌体货物的机制、它们在泌尿生殖系统癌症中的作用,以及它们作为液体活检候选生物标志物的潜在临床应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a201/9760437/4b5186439685/ijbsv19p0167g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a201/9760437/10bd7c99cf13/ijbsv19p0167g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a201/9760437/4b5186439685/ijbsv19p0167g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a201/9760437/10bd7c99cf13/ijbsv19p0167g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a201/9760437/4b5186439685/ijbsv19p0167g002.jpg

相似文献

1
Exosomes in Genitourinary Cancers: Emerging Mediators of Drug Resistance and Promising Biomarkers.泌尿道癌症中的外泌体:新兴的药物耐药性介质和有前途的生物标志物。
Int J Biol Sci. 2023 Jan 1;19(1):167-182. doi: 10.7150/ijbs.78321. eCollection 2023.
2
Biological functions and clinical applications of exosomal long non-coding RNAs in cancer.外泌体长链非编码 RNA 在癌症中的生物学功能和临床应用。
J Cell Mol Med. 2020 Oct;24(20):11656-11666. doi: 10.1111/jcmm.15873. Epub 2020 Sep 14.
3
Exosomes in Liquid Biopsy: A Nanotool for Postradiotherapy Cancer Monitoring.液体活检中的外泌体:放疗后癌症监测的纳米工具。
Front Biosci (Landmark Ed). 2022 Jun 27;27(7):205. doi: 10.31083/j.fbl2707205.
4
Exosomes as a new frontier of cancer liquid biopsy.外泌体作为癌症液体活检的新前沿。
Mol Cancer. 2022 Feb 18;21(1):56. doi: 10.1186/s12943-022-01509-9.
5
Power and promise of exosomes as clinical biomarkers and therapeutic vectors for liquid biopsy and cancer control.外泌体作为液体活检和癌症控制的临床生物标志物和治疗载体的潜力和前景。
Biochim Biophys Acta Rev Cancer. 2021 Jan;1875(1):188497. doi: 10.1016/j.bbcan.2020.188497. Epub 2020 Dec 25.
6
Biological functions and clinical applications of exosomal non-coding RNAs in hepatocellular carcinoma.外泌体非编码 RNA 在肝细胞癌中的生物学功能和临床应用。
Cell Mol Life Sci. 2019 Nov;76(21):4203-4219. doi: 10.1007/s00018-019-03215-0. Epub 2019 Jul 12.
7
Multiple Roles of Exosomal Long Noncoding RNAs in Cancers.外泌体长链非编码 RNA 在癌症中的多种作用。
Biomed Res Int. 2019 Jul 7;2019:1460572. doi: 10.1155/2019/1460572. eCollection 2019.
8
The functional roles of exosomal long non-coding RNAs in cancer.外泌体长链非编码 RNA 在癌症中的功能作用。
Cell Mol Life Sci. 2019 Jun;76(11):2059-2076. doi: 10.1007/s00018-019-03018-3. Epub 2019 Jan 25.
9
Emerging role of exosome-shuttled noncoding RNAs in gastrointestinal cancers: From intercellular crosstalk to clinical utility.外泌体源性非编码 RNA 在胃肠道肿瘤中的作用:从细胞间通讯到临床应用。
Pharmacol Res. 2023 Sep;195:106880. doi: 10.1016/j.phrs.2023.106880. Epub 2023 Aug 3.
10
Exosomes as a liquid biopsy for lung cancer.外泌体作为肺癌的液体活检。
Lung Cancer. 2018 Feb;116:46-54. doi: 10.1016/j.lungcan.2017.12.012. Epub 2017 Dec 18.

引用本文的文献

1
Genotype-Specific Small EVs Released by Giardia lamblia Act as Mediators of Phenotypic Adaptation Under Metronidazole-Induced Stress.贾第虫释放的基因型特异性小细胞外囊泡在甲硝唑诱导的应激下作为表型适应的介质。
J Extracell Vesicles. 2025 Sep;14(9):e70139. doi: 10.1002/jev2.70139.
2
Harnessing Natural Products to Surmount Drug Resistance in Gastric Cancer: Mechanisms and Therapeutic Perspectives.利用天然产物克服胃癌耐药性:机制与治疗前景
Int J Biol Sci. 2025 Jul 11;21(10):4604-4628. doi: 10.7150/ijbs.113709. eCollection 2025.
3
Exosomal miRNAs: A New Frontier in Cardiovascular Disease Diagnosis and Treatment.

本文引用的文献

1
Exosomes derived from myeloid-derived suppressor cells facilitate castration-resistant prostate cancer progression via S100A9/circMID1/miR-506-3p/MID1.髓源性抑制细胞来源的外泌体通过 S100A9/circMID1/miR-506-3p/MID1 促进去势抵抗性前列腺癌的进展。
J Transl Med. 2022 Aug 2;20(1):346. doi: 10.1186/s12967-022-03494-5.
2
Exosomal Circsafb2 Reshaping Tumor Environment to Promote Renal Cell Carcinoma Progression by Mediating M2 Macrophage Polarization.外泌体Circsafb2通过介导M2巨噬细胞极化重塑肿瘤微环境以促进肾细胞癌进展。
Front Oncol. 2022 May 12;12:808888. doi: 10.3389/fonc.2022.808888. eCollection 2022.
3
外泌体微小RNA:心血管疾病诊断与治疗的新前沿
J Cardiovasc Transl Res. 2025 Jun 19. doi: 10.1007/s12265-025-10617-y.
4
Role of extracellular vesicles in cancer: implications in immunotherapeutic resistance.细胞外囊泡在癌症中的作用:对免疫治疗耐药性的影响
Front Immunol. 2025 May 22;16:1581635. doi: 10.3389/fimmu.2025.1581635. eCollection 2025.
5
Unraveling exosome-mediated cancer therapy resistance: pathways and therapeutic challenges.解析外泌体介导的癌症治疗耐药性:途径与治疗挑战
J Egypt Natl Canc Inst. 2025 May 1;37(1):30. doi: 10.1186/s43046-025-00289-9.
6
The role and clinical applications of exosomes in cancer drug resistance.外泌体在癌症耐药中的作用及临床应用
Cancer Drug Resist. 2024 Nov 4;7:43. doi: 10.20517/cdr.2024.97. eCollection 2024.
7
Different origin-derived exosomes and their clinical advantages in cancer therapy.不同来源的外泌体及其在癌症治疗中的临床优势。
Front Immunol. 2024 Jun 27;15:1401852. doi: 10.3389/fimmu.2024.1401852. eCollection 2024.
8
Unraveling the Multifaceted Roles of Extracellular Vesicles: Insights into Biology, Pharmacology, and Pharmaceutical Applications for Drug Delivery.解析细胞外囊泡的多面角色:在生物学、药理学和药物递送的药物应用方面的深入见解。
Int J Mol Sci. 2023 Dec 29;25(1):485. doi: 10.3390/ijms25010485.
9
Biological, pathological, and multifaceted therapeutic functions of exosomes to target cancer.外泌体针对癌症的生物学、病理学和多方面治疗功能。
Oncol Res. 2023 Nov 15;32(1):73-94. doi: 10.32604/or.2023.030401. eCollection 2023.
Macitentan improves antitumor immune responses by inhibiting the secretion of tumor-derived extracellular vesicle PD-L1.
马西替坦通过抑制肿瘤来源的细胞外囊泡 PD-L1 的分泌来改善抗肿瘤免疫反应。
Theranostics. 2022 Jan 31;12(5):1971-1987. doi: 10.7150/thno.68864. eCollection 2022.
4
Tumor-derived exosomes facilitate tumor cells escape from drug therapy in clear cell renal cell carcinoma.肿瘤来源的外泌体促进透明细胞肾细胞癌中的肿瘤细胞逃避药物治疗。
Transl Cancer Res. 2020 May;9(5):3416-3425. doi: 10.21037/tcr-19-2246.
5
Cancer statistics, 2022.癌症统计数据,2022 年。
CA Cancer J Clin. 2022 Jan;72(1):7-33. doi: 10.3322/caac.21708. Epub 2022 Jan 12.
6
The emerging roles of exosomal long non-coding RNAs in bladder cancer.外泌体长链非编码 RNA 在膀胱癌中的新兴作用。
J Cell Mol Med. 2022 Feb;26(4):966-976. doi: 10.1111/jcmm.17152. Epub 2022 Jan 3.
7
Assessment of Out-of-Pocket Costs With Rebate Pass-through for Brand-name Cancer Drugs Under Medicare Part D.评估医疗保险部分 D 下品牌癌症药物通过回扣传递的自付费用。
JAMA Oncol. 2022 Jan 1;8(1):155-156. doi: 10.1001/jamaoncol.2021.5433.
8
Cancer cell-derived exosomal circUSP7 induces CD8 T cell dysfunction and anti-PD1 resistance by regulating the miR-934/SHP2 axis in NSCLC.肿瘤细胞来源的外泌体 circUSP7 通过调控非小细胞肺癌中 miR-934/SHP2 轴诱导 CD8 T 细胞功能障碍和抗 PD-1 耐药。
Mol Cancer. 2021 Nov 9;20(1):144. doi: 10.1186/s12943-021-01448-x.
9
Exosome-mediated transfer of SNHG7 enhances docetaxel resistance in lung adenocarcinoma.外泌体介导的 SNHG7 转移增强了肺腺癌对多西他赛的耐药性。
Cancer Lett. 2022 Feb 1;526:142-154. doi: 10.1016/j.canlet.2021.10.029. Epub 2021 Oct 27.
10
Exosomes as mediators of intercellular crosstalk in metabolism.外泌体作为细胞间代谢通讯的介质。
Cell Metab. 2021 Sep 7;33(9):1744-1762. doi: 10.1016/j.cmet.2021.08.006.